Category: AMERICA

LIVE on June 17, 10 AM ET: CDC Advisers Discuss COVID-19 Vaccines for Young Children

The Advisory Committee on Immunization Practices (ACIP) holds a virtual meeting to discuss COVID-19 vaccines for young children. Find more info here. * Click the “Save” button below the video to access it later on “My List.” Follow EpochTV on social media: Twitter: https://twitter.com/EpochTVus Rumble: https://rumble.com/c/EpochTV Truth Social: https://truthsocial.com/@EpochTV Gettr: https://gettr.com/user/epochtv Facebook: https://www.facebook.com/EpochTVus Gab: https://gab.com/EpochTV Telegram:…


Biden Administration Plans to Extend COVID-19 Emergency, Official Suggests

President Joe Biden’s administration plans to extend the emergency declaration over COVID-19 before it expires, an official indicated on June 16. Dawn O’Connell, the administration’s assistant secretary for preparedness and response, said on Capitol Hill during a Senate hearing that the administration is sticking with its promise to give states ample notice prior to terminating…


Fauci Joins Senate Hearing Remotely After Testing Positive for COVID-19

Dr. Anthony Fauci on June 16 joined a Senate hearing after testing positive for COVID-19. Fauci, 81, President Joe Biden’s chief medical adviser, tested positive on Wednesday. The National Institutes of Health, which employs Fauci, said the doctor was experiencing mild symptoms. Fauci has received not only a primary series of a COVID-19 vaccine, but…


Pfizer Stops Enrollment in Paxlovid Trial for Less Vulnerable COVID-19 Patients

Pfizer has announced it will stop enrollment in a clinical trial for Paxlovid—its COVID-19 antiviral pill—for standard-risk COVID-19 patients after the latest results suggested the drug did not reduce symptoms or hospitalizations and deaths to a statistically significant degree. Paxlovid, which consists of two different antiviral drugs—nirmatrelvir and ritonavir—is currently approved or authorized for conditional or…


Pfizer Stops Enrollment in COVID-19 Pill Trial After Drug Performs Poorly

Pfizer has announced it will stop enrollment in a clinical trial for Paxlovid—its COVID-19 antiviral pill—for standard-risk COVID-19 patients after the latest results suggested the drug did not reduce symptoms or hospitalizations and deaths to a statistically significant degree. Paxlovid, which consists of two different antiviral drugs—nirmatrelvir and ritonavir—is currently approved or authorized for conditional or…


Pfizer Stops Enrollment in COVID-19 Pill Trial After Latest Results

Pfizer has announced it will stop enrollment in a clinical trial for Paxlovid—its COVID-19 antiviral pill—for standard-risk COVID-19 patients after the latest results suggested the drug did not reduce symptoms or hospitalizations and deaths to a statistically significant degree. Paxlovid, which consists of two different antiviral drugs—nirmatrelvir and ritonavir—is currently approved or authorized for conditional or…


Rick Scott to the Rescue

Sen. Rick Scott of Florida has proposed a 12-point plan to rescue America from Joe Biden’s disastrous policies. Rather than waiting for the November midterms, Scott is getting ahead of them and laying out solutions to our current problems and decline, and I break down all 12 points to find out what substantive solutions might…


‘Natural Immunity Wins Again’: Study Demonstrates Infection-Derived Immunity Likely Superior to COVID Vaccines

A new study published by the New England Journal of Medicine on June 9 found that protection from COVID-19 via natural immunity was superior to that of two doses of Pfizer’s COVID vaccine after the same amount of time elapsed among uninfected people. “Natural immunity wins again,” Martin Adel Makary, M.D., M.P.H., a public policy researcher…


FDA Advisory Panel Recommends Moderna and Pfizer COVID-19 Vaccines for Babies, Toddlers

A Food and Drug Administration (FDA) advisory panel on June 15 voted to recommend the FDA give emergency authorization to the Moderna and Pfizer COVID-19 vaccines for children as young as 6 months of age. The panel unanimously voted during a virtual meeting after presentations from the companies and the FDA. The FDA has yet…


Two NY Federal Judges Consecutively Step Down From Vaccine Mandate Lawsuits Over Ownership of Pfizer Stock

An Obama-appointed federal judge in New York who owns between $50,000 and $100,000 worth of Pfizer stock has recused herself to avoid the possible appearance of bias or prejudice since she was overseeing a case of NYC teachers trying to get exemptions to the COVID vaccines. Recusal, in legal terms, means that a judge excuses him…